Caxton Associates (New York)’s Sabra Healthcare REIT SBRA Stock Holding History

Caxton Associates (New York)’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-152,775	Closed	-$2.84M	–	652
2024 Q3	$2.84M	Sell	152,775 -31,819	-17%	-$536K	0.11%	72
2024 Q2	$2.84M	Buy	+184,594	New	+$2.64M	0.1%	112
2023 Q2	–	Sell	-11,531	Closed	-$133K	–	634
2023 Q1	$133K	Hold	11,531	–	–	0.02%	449
2022 Q4	$143K	Buy	+11,531	New	+$147K	0.01%	406
2022 Q3	–	Sell	-23,439	Closed	-$327K	–	648
2022 Q2	$327K	Sell	23,439 -32,534	-58%	-$435K	0.03%	357
2022 Q1	$833K	Buy	55,973 +18,300	+49%	+$250K	0.07%	139
2021 Q4	$510K	Buy	+37,673	New	+$533K	0.05%	270
2021 Q3	–	Sell	-22,535	Closed	-$410K	–	584
2021 Q2	$410K	Sell	22,535 -13,196	-37%	-$235K	0.05%	227
2021 Q1	$620K	Buy	+35,731	New	+$628K	0.06%	127
2020 Q2	–	Sell	-48,347	Closed	-$528K	–	598
2020 Q1	$528K	Buy	+48,347	New	+$891K	0.1%	152

Other funds holding SBRA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Caxton Associates (New York)'s SBRA Position: Q4 2024 in Review

Caxton Associates (New York) sold out of Sabra Healthcare REIT (SBRA) in Q4 2024, closing a stake of 152,775 shares — an estimated $2.84M sold.

Caxton Associates (New York) first reported a position in SBRA in Q1 2020 and held it in 10 quarters. The position peaked at $2.84M in Q3 2024. 389 funds tracked by Wall St. Rank hold SBRA as of Q4 2024.

Caxton Associates (New York) reported no remaining Sabra Healthcare REIT position as of Q4 2024 after selling out during the quarter.
Caxton Associates (New York) sold 152,775 Sabra Healthcare REIT shares in Q4 2024, an estimated $2.84M.
Caxton Associates (New York) first reported a position in Sabra Healthcare REIT in Q1 2020 and held it in 10 quarters.
Caxton Associates (New York)'s Sabra Healthcare REIT position peaked at $2.84M in Q3 2024.
389 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.